Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jasper Therapeutics Inc. (JSPR)

Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,853
  • Shares Outstanding, K 27,984
  • Annual Sales, $ 0 K
  • Annual Income, $ -71,270 K
  • EBIT $ -93 M
  • EBITDA $ -92 M
  • 60-Month Beta 3.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.50

Options Overview Details

View History
  • Implied Volatility 492.91% (+285.93%)
  • Historical Volatility 94.33%
  • IV Percentile 93%
  • IV Rank 37.43%
  • IV High 1,185.83% on 08/11/25
  • IV Low 78.33% on 10/06/25
  • Expected Move (DTE 13) 0.9095 (53.19%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 296
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 6,714
  • Open Int (30-Day) 5,545
  • Expected Range 0.8005 to 2.6195

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.79
  • Number of Estimates 3
  • High Estimate -0.69
  • Low Estimate -0.99
  • Prior Year -1.62
  • Growth Rate Est. (year over year) +51.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3900 +23.02%
on 12/03/25
2.4199 -29.34%
on 12/02/25
-0.2400 (-12.31%)
since 11/05/25
3-Month
1.3900 +23.02%
on 12/03/25
2.7800 -38.49%
on 09/08/25
-1.0100 (-37.13%)
since 09/05/25
52-Week
1.3900 +23.02%
on 12/03/25
23.8900 -92.84%
on 12/06/24
-19.8200 (-92.06%)
since 12/05/24

Most Recent Stories

More News
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a single 180mg dose of Briquilimab in the ETESIAN Study Preliminary data from...

JSPR : 1.7100 (-8.06%)
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation

REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage biotechnology company focused on development of briquilimab,...

JSPR : 1.7100 (-8.06%)
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options...

JSPR : 1.7100 (-8.06%)
Deadline Soon: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed...

JSPR : 1.7100 (-8.06%)
JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK , Nov. 14, 2025 /PRNewswire/ -- 

JSPR : 1.7100 (-8.06%)
JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options

JSPR : 1.7100 (-8.06%)
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Nov. 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Jasper Therapeutics,...

JSPR : 1.7100 (-8.06%)
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR

LOS ANGELES , Nov. 14, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. ("Jasper" or "the Company") (NASDAQ: JSPR ) for...

JSPR : 1.7100 (-8.06%)
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Nov. 13, 2025 /PRNewswire/ --  The Law Offices of Frank R. Cruz announces that investors with losses related to Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: ...

JSPR : 1.7100 (-8.06%)
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

 

JSPR : 1.7100 (-8.06%)

Business Summary

Jasper Therapeutics Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics Inc., formerly known as Amplitude Healthcare Acquisition Corporation, is based in REDWOOD CITY, Calif.

See More

Key Turning Points

3rd Resistance Point 2.1024
2nd Resistance Point 2.0162
1st Resistance Point 1.8631
Last Price 1.7100
1st Support Level 1.6238
2nd Support Level 1.5376
3rd Support Level 1.3845

See More

52-Week High 23.8900
Fibonacci 61.8% 15.2950
Fibonacci 50% 12.6400
Fibonacci 38.2% 9.9850
Last Price 1.7100
52-Week Low 1.3900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar